Krystal Biotech Near Highs After Insider Filing Ahead of 2026 Data
Krystal Biotech was poised to start Thursday trade just below its 52-week high. A fresh SEC filing showed EVP and general counsel Thomas John Charles sold a small batch of shares using a preset trading plan. KRYS last traded at $306.63, above the midpoint of its $123.03 to $319.48 range for the past year. U.S. markets stayed open. Nasdaq’s 2026 calendar shows markets closed for Memorial Day on May 25 and Juneteenth on June 19. Thursday lands on a normal trading day after the short week.